How to achieve new lipid goals in high-risk patients?
City
Webinar
Type of event
virtual
Invitation
Dear Dr.
The Zurich Heart House would like to invite you to a special webinar on
How to achieve new lipid goals in high-risk patients? From statins, NPC1L1 transport inhibitors to PCSK9 antibodies
Date: Thursday, March 3rd 2022, 17:00 – 18:30 CET
We are looking forward to meeting you during this webinar.
Christian Mueller, Basel
Isabella Sudano, Zurich
Thomas F. Lüscher, Zurich and London
Organized by
Programme
Chairs in ZHH Studio: Christian Mueller, Basel, Isabella Sudano, Zurich, Thomas F. Lüscher, Zurich and London
| 17:00 | Introduction | Christian Mueller, Basel |
| 17:05 | The 2019 ESC/EAS Guidelines and the lipid goals | Francois Mach, Geneva |
| 17:20 | What we achieved so far: statins and ezetimibe | Thomas F. Lüscher, London |
| 17:35 | Effectiveness and safety of the PCSK9 inhibitors | Ulf Landmesser, Berlin |
| 17:50 | Mind the gap: Do we reach the lipid goals in real world? | Thomas Rosemann, Zurich |
| 18:05 | Panel discussion | Faculty |
| 18:25 | Key messages | Isabella Sudano, Zurich |
This programme is supported by Amgen.
The scientific programme has not been influenced in any way by its sponsor.
Accreditation
This webinar has been granted 1 European CME credits by the European Accreditation Council for Continuing Medical Education (EACCME®).